Fundaro Paolo

CIK 00015595371 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001559537

Recent Transactions

50 trades

Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−1,598→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,174→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,966→ 0 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−35,794→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−8,111→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,790→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−275→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,089→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,547→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−1,750→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,036→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,748→ 0 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-05-24+12,547→ 12,547 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-05-24+8,111→ 43,905 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2022-05-25+12,790→ 12,790 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-05-25+7,737→ 35,794 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2021-05-27+12,089→ 12,089 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-27+7,029→ 28,057 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
2020-08-17$50.15/sh−126,888→ 5,235,512 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
2020-08-17$46.75/sh−1,235,512→ 4,000,000 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
2020-08-14$50.55/sh−54,600→ 5,362,400 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
2020-08-13$52.60/sh−83,000→ 5,417,000 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-05-28+1,595→ 21,028 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2020-05-28+2,966→ 2,966 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share
2020-05-13$84.60/sh−595,578→ 5,500,000 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-06-20+2,174→ 2,174 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-06-20+1,570→ 19,433 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-05-20$21.50/sh+3,288→ 17,863 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-05-20−3,288→ 0 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-05-20−3,461→ 0 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-05-20$9.30/sh+3,461→ 14,575 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-03-29$107.45/sh−2,171→ 11,114 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-06-20+1,787→ 13,285 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2018-06-20+2,748→ 2,748 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-06-27+1,423→ 11,498 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2017-06-27+2,036→ 2,036 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2016-07-19+1,204→ 10,075 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2016-07-19+1,598→ 1,598 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2015-11-24+650→ 8,871 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2015-11-24+1,750→ 1,750 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2015-07-24$285.00/sh−582→ 8,221 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-08-11$239.49/sh−324→ 8,803 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-08-09+324→ 9,127 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Restricted Stock Units
2014-08-09−324→ 0 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-07-17+226→ 8,803 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2014-07-17+275→ 275 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-02-14$367.51/sh−324→ 1,655 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-02-12$8.67/sh+3,461→ 5,440 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-02-12$382.00/sh−500→ 2,901 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2014-02-12$383.00/sh−922→ 1,979 total

Companies

INTERCEPT PHARMACEUTICALS, INC.
Director

Recent Filings

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET

NEW YORK, NY, 10013

View on SEC.gov